FDA Panel Supports Omicron-specific Boosters Despite Lack of Safety, Efficacy Data; Biden Places $3.2B Order With Pfizer
July 1, 2022 FDA Panel Supports Omicron-specific Boosters Despite Lack of Safety, Efficacy Data; Biden Places $3.2B Order With Pfizer...